Biogen To Pay $900M To Settle Whistleblower’s MS Drug Kickbacks Lawsuit
[ad_1] Biogen, Inc. BIIB disclosed in its second-quarter earnings report that it recorded $900 million related to a settlement agreement to resolve previously disclosed “qui tam” litigation related to its conduct before 2015.…